JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was THB 122.5 million compared to THB 102.5 million a year ago. Net loss was THB 13.33 million compared to THB 11.85 million a year ago. Basic loss per share from continuing operations was THB 0.03 compared to THB 0.02 a year ago.
For the six months, revenue was THB 245.14 million compared to THB 187.97 million a year ago. Net loss was THB 11.47 million compared to THB 23.44 million a year ago. Basic loss per share from continuing operations was THB 0.02 compared to THB 0.05 a year ago. Diluted loss per share from continuing operations was THB 0.02 compared to THB 0.05 a year ago.